SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-135916
Filing Date
2023-05-04
Accepted
2023-05-04 16:10:37
Documents
14
Period of Report
2023-04-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d216943d8k.htm   iXBRL 8-K 34198
2 EX-10.1 d216943dex101.htm EX-10.1 89678
  Complete submission text file 0001193125-23-135916.txt   317115

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA amam-20230428.xsd EX-101.SCH 3656
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amam-20230428_def.xml EX-101.DEF 14112
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE amam-20230428_lab.xml EX-101.LAB 23899
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amam-20230428_pre.xml EX-101.PRE 14992
8 EXTRACTED XBRL INSTANCE DOCUMENT d216943d8k_htm.xml XML 6169
Mailing Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037
Business Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037 (858) 875-2400
Ambrx Biopharma Inc. (Filer) CIK: 0001836056 (see all company filings)

IRS No.: 571147346 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40505 | Film No.: 23888784
SIC: 2836 Biological Products, (No Diagnostic Substances)